Sanara Medtech Inc
SMTI24.370USD
+0.210+0.87%
Market hours （ET）Quotes delayed by 15 min
216.98MMarket Cap
LossP/E TTM
More Details of Sanara Medtech Inc Company
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Company Info
Ticker SymbolSMTI
Company nameSanara Medtech Inc
IPO dateApr 07, 1994
CEOMr. Suresh V. (Sam) Muppalla
Number of employees141
Security typeOrdinary Share
Fiscal year-endApr 07
Address1200 Summit Avenue
CityFORT WORTH
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code76102
Phone18175292300
Websitehttps://sanaramedtech.com/
Ticker SymbolSMTI
IPO dateApr 07, 1994
CEOMr. Suresh V. (Sam) Muppalla
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
64.04K
--
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Commercial Officer
President, Chief Commercial Officer
61.29K
-7.44%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
64.04K
--
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Commercial Officer
President, Chief Commercial Officer
61.29K
-7.44%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Soft tissue repair products
20.53M
87.62%
Bone fusion products
2.90M
12.38%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Soft tissue repair products
20.53M
87.62%
Bone fusion products
2.90M
12.38%
Shareholding Stats
Updated: Thu, May 29
Updated: Thu, May 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
FA Sanara, L.L.C.
39.51%
Stuckert (James W)
10.88%
Tall Pines Capital LLC
5.77%
Howell (Solomon Oden Jr)
5.52%
The Vanguard Group, Inc.
2.21%
Other
36.11%
Shareholders
Shareholders
Proportion
FA Sanara, L.L.C.
39.51%
Stuckert (James W)
10.88%
Tall Pines Capital LLC
5.77%
Howell (Solomon Oden Jr)
5.52%
The Vanguard Group, Inc.
2.21%
Other
36.11%
Shareholder Types
Shareholders
Proportion
Corporation
45.28%
Individual Investor
20.06%
Investment Advisor
6.63%
Investment Advisor/Hedge Fund
3.35%
Research Firm
0.77%
Hedge Fund
0.56%
Bank and Trust
0.12%
Pension Fund
0.11%
Insurance Company
0.02%
Other
23.09%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
125
6.84M
76.91%
+482.04K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
2023Q1
75
5.66M
71.11%
-305.86K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
FA Sanara, L.L.C.
3.51M
39.51%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.88%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.77%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.52%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
196.47K
2.21%
-4.33K
-2.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
193.22K
2.17%
-3.99K
-2.02%
Mar 31, 2025
Stonebridge Wealth Management, LLC
100.06K
1.13%
+100.06K
--
Sep 30, 2024
Geode Capital Management, L.L.C.
88.75K
1%
+881.00
+1.00%
Mar 31, 2025
Nixon (Ronald T)
64.04K
0.72%
--
--
Apr 11, 2025
State Street Global Advisors (US)
63.28K
0.71%
-900.00
-1.40%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
View more
WisdomTree US SmallCap Fund
Proportion0.03%
iShares Micro-Cap ETF
Proportion0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
